SynthesisSystematic reviews2025

Optimal daratumumab-based regimen for patients with newly diagnosed and previously untreated multiple myeloma: systematic review and component network meta-analysis.

Xiaohua Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.